000 01404 a2200409 4500
005 20250513102438.0
264 0 _c19970305
008 199703s 0 0 eng d
022 _a0959-4973
024 7 _a10.1097/00001813-199607000-00003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCarbonell, E
245 0 0 _aCytogenetic analysis in peripheral lymphocytes of cancer patients treated with cytostatic drugs: results from an EC Collaborative Study.
_h[electronic resource]
260 _bAnti-cancer drugs
_cJul 1996
300 _a514-9 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aChromosome Aberrations
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLymphocytes
_xdrug effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMutagens
_xadverse effects
650 0 4 _aMutation
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aSister Chromatid Exchange
700 1 _aDemopoulos, N A
700 1 _aStefanou, G
700 1 _aPsaraki, K
700 1 _aParry, K M
700 1 _aMarcos, R
773 0 _tAnti-cancer drugs
_gvol. 7
_gno. 5
_gp. 514-9
856 4 0 _uhttps://doi.org/10.1097/00001813-199607000-00003
_zAvailable from publisher's website
999 _c8855529
_d8855529